THURSDAY, Dec. 5, 2024 (HealthDay News) -- Specific pesticides are associated with an increased risk for rheumatoid arthritis among older adults, according to a study published online Dec. ...
THURSDAY, Dec. 5, 2024 (HealthDay News) -- The impact of socioeconomic factors on disease activity in rheumatoid arthritis (RA) varies by academic or safety net hospital setting, according ...
XG005, a non-opioid oral agent, showed strong efficacy and tolerability in relieving knee OA symptoms in a phase 2b trial, offering a promising treatment option....
The mortality risk in patients with pre-existing auto-immune disease is not significantly different from those without AIDS, in an immune checkpoint inhibitor study....
After patients with granulomatosis with polyangiitis achieve remission, discontinuing glucocorticoids could be a viable option....
A systematic review has found that the globalization of recruitment significantly contributes to the higher placebo rates observed in recent psoriatic arthritis clinical trials....
In the SELECT-GCA trial, upadacitinib was found to be superior in comparison to a placebo in patients with giant cell arteritis....
1. Isaclimab significantly improved disease activity at 150 mg and 600 mg doses. 2. Adverse events were comparable between cohorts with no deaths reported. Evidence Rating Level: 1 (Excellen...
1. BMD may differ on paretic and nonparetic sides in stroke patients with a history of falling and balance deficits Evidence Rating Level: 2 (Good) There is an increased risk of fracture d...
The following is a summary of “Chronic widespread musculoskeletal pain shares a highly heritable latent pathway with atherosclerosis and arterial stiffness,” published in the December 20...
TUESDAY, Dec. 3, 2024 (HealthDay News) -- Preferential promotion of White men within academic medicine is persisting, with racially and ethnically diverse women experiencing greater underpr...
The following is a summary of “Psychometric properties of performance based tests in patients with Fibromyalgia: A systematic review,” published in the November 2024 issue of Pain by Soc...
1. The use of rituximab, abatacept and Janus kinase inhibitors (JAKis) in individuals with rheumatoid arthritis (RA) was associated with a statistically significant higher risk of cancer inc...
The following is a summary of “Pulmonary involvement in systemic sclerosis: can sex play a role?” published in the November 2024 issue of Rheumatology by Koletsos et al. Systemi...
TUESDAY, Nov. 26, 2024 (HealthDay News) -- Poor control over specific aspects of work is associated with burnout among physicians, according to a study published online Nov. 26 in the Annal...
The following is a summary of “Characterization of non-IgA vasculitis: Demographic, clinical, and treatment-related features in a retrospective analysis of 28 biopsy-confirmed cases from a...
The following is a summary of “A mobile app to support self-management and remotely monitor disease impact in rheumatoid arthritis: the randomised controlled AEGORA trial,” published in ...
The annual meeting of the American College of Rheumatology was held this year from Nov. 14 to 19 in Washington, D.C., and attendees included rheumatology specialists, physicians, ...
The following is a summary of “Proposal of a radiation-free screening protocol for early detection of interstitial lung involvement in seropositive and ACPA-positive rheumatoid arthritis,...
Patients with moderate-to-severe active Sjögren’s disease who received nipocalimab showed improvements in disease activity....
The latest articles and insights from your colleagues in your specialty(ies) of choice.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
